HYDRALAZINE-PYRIMIDINE INTERACTIONS MAY EXPLAIN HYDRALAZINE-INDUCED LUPUS-ERYTHEMATOSUS

被引：86

作者：

DUBROFF, LM

REID, RJ

机构：

来源：

关键词：

D O I：

10.1126/science.7367866

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：404 / 406

页数：3

共 20 条

[11] IMMUNE-RESPONSES TO HYDRALAZINE AND NUCLEAR ANTIGENS IN HYDRALAZINE-INDUCED LUPUS-ERYTHEMATOSUS
HAHN, BH
IRVIN, WS
KANTOR, OS
BAGBY, MK
SHARP, GC
GARDNER, CA
OSTERLAND, CK
PERRY, HM
[J]. ANNALS OF INTERNAL MEDICINE, 1972, 76 (03) : 365 - +
[12] PERSISTENCE OF THE HYDRALAZINE SYNDROME - A FOLLOW-UP STUDY OF 11 CASES
HILDRETH, EA
BIRO, CE
MCCREARY, TA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 173 (06): : 657 - 660
[13] AGARITINE - ISOLATION, DEGRADATION, AND SYNTHESIS
KELLY, RB
HINMAN, JW
DANIELS, EG
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1962, 27 (09) : 3229 - &
[14] ACTIVATION OF SYSTEMIC LUPUS ERYTHEMATOSUS BY DRUGS
LEE, SL
RIVERO, I
SIEGEL, M
[J]. ARCHIVES OF INTERNAL MEDICINE, 1966, 117 (05) : 620 - &
[15] SHAPIRO H, 1968, METHODS ENZYMOL A, V12, P212
[16] STOLLAR BD, 1973, ANTIGENS, P1
[17] TALSETH T, 1977, CLIN PHARMACOL THER, V21, P715
[18] TAN E, 1978, IMMUNOLOGICAL DISEAS, V2, P1078
[19] TAN EM, 1974, FED PROC, V33, P1894
[20] TOTH B, 1975, CANCER RES, V35, P3693